BRIDGEWAY CAPITAL MANAGEMENT, LLC - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 66 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$138,195
-53.3%
249,0000.0%0.00%
-50.0%
Q3 2022$296,000
+88.5%
249,0000.0%0.01%
+100.0%
Q2 2022$157,000
-50.8%
249,000
-11.1%
0.00%
-33.3%
Q1 2022$319,000
+1.3%
280,000
+100.0%
0.01%0.0%
Q4 2021$315,000
-77.2%
140,000
-65.3%
0.01%
-76.9%
Q3 2021$1,379,000
-15.4%
403,100
-26.1%
0.03%
-10.3%
Q2 2021$1,630,000
+22.8%
545,300
+32.7%
0.03%
+16.0%
Q1 2021$1,327,000
+49.3%
410,800
-2.0%
0.02%
+31.6%
Q4 2020$889,000
+81.1%
419,3000.0%0.02%
+72.7%
Q3 2020$491,000
+29.6%
419,3000.0%0.01%
+37.5%
Q2 2020$379,000
+10.5%
419,300
+2.3%
0.01%0.0%
Q1 2020$343,000
-28.1%
410,000
-17.5%
0.01%
+33.3%
Q4 2019$477,000
-6.8%
496,9000.0%0.01%
-14.3%
Q3 2019$512,000
-42.7%
496,9000.0%0.01%
-36.4%
Q2 2019$894,000
+7.5%
496,900
+12.3%
0.01%
+10.0%
Q1 2019$832,000
+152.9%
442,500
+58.6%
0.01%
+150.0%
Q4 2018$329,000
-73.6%
279,000
-39.2%
0.00%
-66.7%
Q3 2018$1,244,000
+41.8%
459,0000.0%0.01%
+33.3%
Q2 2018$877,000
-9.0%
459,0000.0%0.01%
-10.0%
Q1 2018$964,000
+3.4%
459,0000.0%0.01%0.0%
Q4 2017$932,000
+52.8%
459,0000.0%0.01%
+42.9%
Q3 2017$610,000
+86.0%
459,000
+119.6%
0.01%
+75.0%
Q2 2017$328,000
-64.8%
209,000
-27.7%
0.00%
-63.6%
Q1 2017$933,000
+135.0%
289,000
-1.6%
0.01%
+120.0%
Q4 2016$397,000
-13.3%
293,8000.0%0.01%
-28.6%
Q3 2016$458,000293,8000.01%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
BVF INC/IL 6,353,645$7,561,0000.31%
SPHERA FUNDS MANAGEMENT LTD. 1,476,000$1,756,0000.24%
EAM Investors, LLC 840,556$1,000,0000.22%
Gratus Capital, LLC 1,249,248$1,487,0000.16%
Ally Bridge Group (NY) LLC 86,242$103,0000.07%
MARINER INDEPENDENT ADVISOR NETWORK, LLC 1,252,822$1,491,0000.06%
Bleichroeder LP 250,000$298,0000.06%
GSA CAPITAL PARTNERS LLP 324,784$386,0000.05%
Polar Capital Holdings Plc 5,000,000$5,950,0000.04%
PLATINUM INVESTMENT MANAGEMENT LTD 545,508$649,0000.03%
View complete list of INFINITY PHARMACEUTICALS INC shareholders